Welcome to our dedicated page for Healthlynked news (Ticker: HLYK), a resource for investors and traders seeking the latest updates and insights on Healthlynked stock.
HealthLynked Corp. (HLYK) provides a cloud-based healthcare connectivity platform transforming patient-provider interactions. This news hub offers investors and healthcare professionals essential updates about the company's strategic initiatives and market position.
Access real-time information on earnings announcements, technology partnerships, and platform enhancements that drive innovation in telemedicine and medical data management. Our curated collection includes press releases about clinical network expansions, regulatory milestones, and operational developments impacting healthcare delivery.
Key updates cover HLYK's progress in patient engagement solutions, EMR integration advancements, and collaborations with healthcare providers. Stay informed about initiatives improving care coordination through AI-driven scheduling tools and secure health data exchange protocols.
Bookmark this page for streamlined access to verified HealthLynked disclosures. Monitor critical developments affecting the company's role in digital healthcare infrastructure without navigating multiple sources.
HealthLynked Corp. (OTCQB: HLYK) reported its financial results for the year and fourth quarter ending December 31, 2022. Revenue fell by 10% to $5.86 million compared to $6.50 million in 2021, primarily due to decreased patient service revenues. An impairment charge of $2.75 million was taken for intangible assets linked to MedOfficeDirect, which has faced declining revenues. However, the company anticipates revenue growth in 2023 from recent initiatives and acquired practices. Net losses decreased to $8.82 million in 2022 from $10.41 million in 2021. The company sold its ACO/MSO business in January 2023 and expects additional payments from this transaction by July 2023.
